Security agreement

Sonic Foundry® Secures $8.5 Million in Debt Financing

Retrieved on: 
Monday, November 21, 2022
Internet, Audio, Video, Apps, Applications, Technology, Software, NBE, Sonic Foundry, GLX, Environment, Risk, News, Security agreement, SOFO, Promissory note, Fred, Foundry, Security, Bank

Sonic Foundry, Inc. (Sonic Foundry or the Company) (NASDAQ: SOFO), the trusted leader in video capture, management and streaming solutions, today announced that it has secured $9.7 million in financing with three separate transactions.

Key Points: 
  • Sonic Foundry, Inc. (Sonic Foundry or the Company) (NASDAQ: SOFO), the trusted leader in video capture, management and streaming solutions, today announced that it has secured $9.7 million in financing with three separate transactions.
  • In addition, the Company closed a Security Agreement and Promissory Note with Mark Burish, Chairman of the Sonic Foundry Board, for $3 million at the same interest rate as the NBE note.
  • Mark Burish, Chairman of the Sonic Foundry Board, added, These financing transactions, including my personal participation, demonstrate the tremendous confidence that our board has in Sonic Foundrys future.
  • Its also important to note that the debt agreement was headed by Fred Kopko, who is managing director of NBE and a former board member of Sonic Foundry.

iSun Inc. Secures $25 million Debt Facility

Retrieved on: 
Tuesday, November 8, 2022
Nuclear, Technology, Other Energy, Environment, Utilities, Oil, Gas, Coal, Alternative Energy, Energy, Urban Planning, REIT, Landscape, Interior Design, Automotive, Architecture, Building Systems, Other Natural Resources, Natural Resources, Other Technology, General Automotive, Other Construction & Property, Commercial Building & Real Estate, Hardware, Construction & Property, Senior, NASDAQ, Bill, Climate change, Asset purchase agreement, Register, U.S. Securities and Exchange Commission, Industry, Phrase, Adoption, EV, Security, SEC, Company, Risk, Private Securities Litigation Reform Act, Maintenance, Securities Exchange Act of 1934, Securities Act of 1933, Second mortgage, EBITDA, Common, Security agreement, Registration statement, Trademark, Solar energy, Common stock, Conversion, Fortune 500, Solution, Annual report, Purchasing, Security (finance), Sale, Renewable energy, Histan, Note

iSun, Inc. (NASDAQ: ISUN) (the "Company," or "iSun"), a leading solar energy and clean mobility infrastructure company with 50-years of experience accelerating the adoption of innovative electrical technologies, announces that it has entered into a debt financing agreement for up to $25 million in Senior Secured Convertible Notes facility (the Notes) with a single institutional investor (the Lender).

Key Points: 
  • iSun, Inc. (NASDAQ: ISUN) (the "Company," or "iSun"), a leading solar energy and clean mobility infrastructure company with 50-years of experience accelerating the adoption of innovative electrical technologies, announces that it has entered into a debt financing agreement for up to $25 million in Senior Secured Convertible Notes facility (the Notes) with a single institutional investor (the Lender).
  • We continue to see significant interest and enthusiasm for the products and services that iSun provides to our growing customer base said Jeffrey Peck, Chairman and Chief Executive Officer of iSun.
  • This debt facility validates our commitment to accelerating the transition to clean energy as we continue our fight against climate change while providing an opportunity to strengthen our balance sheet.
  • A.G.P./Alliance Global Partners acted as sole placement agent for the financing, and Merritt & Merritt acted as the Companys legal counsel.

Vapotherm Announces Debt Amendment and NYSE Continued Listing Standard Notice

Retrieved on: 
Monday, October 3, 2022
General Health, Health, Other Health, Medical Devices, Regulation, Second Amendment to the United States Constitution, Achievement, Breathe Me, Hypercapnia, Regulation Fair Disclosure, Security, Compliance, Food, U.S. Securities and Exchange Commission, VAPO, Private Securities Litigation Reform Act, Hypoxemia, Patent, Failure, COVID-19, District of Columbia Voting Rights Amendment, Finance Secretary (India), Food and Drug Administration, Notice, Gas, LIBOR, NYSE, Plan, Security (finance), Patient, Risk, Investor relations, Term, Security agreement, Company, Vapotherm

In accordance with the NYSE rules, the Company intends to notify the NYSE within 10 business days of receipt of the Notice that the Company intends to cure the deficiency.

Key Points: 
  • In accordance with the NYSE rules, the Company intends to notify the NYSE within 10 business days of receipt of the Notice that the Company intends to cure the deficiency.
  • Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA.
  • Vapotherm high velocity therapy is mask-free noninvasive ventilatory support and is a front-line tool for relieving respiratory distressincluding hypercapnia, hypoxemia, and dyspnea.
  • This press release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties, including its intent to regain compliance with the NYSE continued listing standards.

SQI Diagnostics Inc. Announces Closing of $4.05 Million Debt Financing

Retrieved on: 
Friday, June 17, 2022
Debenture, COVID-19, Science, Person, SQI, Compliance, SEDAR, Multilateral, Company, Security, Finance Secretary (India), Informatics, FOR, Marketing, Securities Act of 1933, Regulation, Minority, News, Policy, Security agreement, MI, OF, TSX Venture Exchange, NOT, Offering, PCR, Security (finance)

SQI intends to use the net proceeds of the Offering to fund the Company's product commercialization and manufacturing programs, sales and marketing and for general working capital purposes.

Key Points: 
  • SQI intends to use the net proceeds of the Offering to fund the Company's product commercialization and manufacturing programs, sales and marketing and for general working capital purposes.
  • The Debentures were purchased by three insiders of the Company, who are control persons of the Company.
  • SQI relied on exemptions from the formal valuation and minority approval requirements in sections 5.5(b) and 5.7(f) of MI 61-101 in respect of such insider participation.
  • SQI Diagnostics are leaders in the science of lung health.

Quantum Reports Preliminary Revenue Results for Fourth Quarter Fiscal 2022 and Provides Update on Debt Arrangements

Retrieved on: 
Monday, April 11, 2022
Company, 3rd Floor, Exercise, Life, Face, Organization, Risk, Form 10-K, Mission statement, Aggression, NASDAQ, Security agreement, Sale, Form, Russell, Transport, Quantum Corporation, Overalls, Rights, Form S-3, Research, SEC, Restatements of the Law, Security, Environment, CEO, U.S. Securities and Exchange Commission, Intelligence, Communication, Government, Foreign Exchange Committee, Prospectus, Terrorism, EDGAR, LLC, Software, Securities Exchange Act of 1934, Securities Act of 1933, COVID-19, Phrase, Solution, SAN, Education, Security (finance), Video game, Bank, Nasdaq, Quantum

SAN JOSE, Calif., April 11, 2022 /PRNewswire/ -- Quantum Corporation (NASDAQ: QMCO) announced today preliminary revenue results for its fiscal fourth quarter ended March 31, 2022.

Key Points: 
  • SAN JOSE, Calif., April 11, 2022 /PRNewswire/ -- Quantum Corporation (NASDAQ: QMCO) announced today preliminary revenue results for its fiscal fourth quarter ended March 31, 2022.
  • "I am pleased to report stronger preliminary revenue results for the fourth quarter," said Jamie Lerner, Chairman and CEO of Quantum.
  • Quantum has not completed preparation of its financial statements for its fiscal fourth quarter and fiscal year 2022.
  • Quantum will report its complete financial results and other metrics during its fiscal fourth quarter and fiscal year 2022 conference call in early June.

Quantum Corporation Announces Rights Offering

Retrieved on: 
Thursday, March 17, 2022
Common, SEC, Special-purpose acquisition company, U.S. Securities and Exchange Commission, Common stock, Board of directors, Form, Nasdaq, Exercise, LLC, Compliance, Security agreement, Security, Investment, Security (finance), Restatements of the Law, Board, Sale, Company, Prospectus, Quantum Corporation, Date, SAN, LP, Neuberger Berman

If the rights offering is fully subscribed, the Company expects to receive gross proceeds of approximately $67.5 million, before expenses related to the rights offering.

Key Points: 
  • If the rights offering is fully subscribed, the Company expects to receive gross proceeds of approximately $67.5 million, before expenses related to the rights offering.
  • The rights offering will include an over-subscription right to permit each rights holder that exercises its basic subscription rights in full to purchase additional shares of Common Stock that remain unsubscribed at the expiration of the offering.
  • The availability of over-subscription rights will be subject to certain terms and conditions, including pro rata adjustments (if any), to be set forth in the offering documents.
  • The Company will have broad discretion as to the use of any proceeds from the rights offering.

Patrick Clancey Appointed Chief Executive Officer of IDEMIA National Security Solutions

Retrieved on: 
Monday, January 24, 2022
Technology, Professional Services, Security, Homeland Security, Software, Other Defense, Defense, Contracts, Public Policy, Government, Human Resources, Hardware, Identity, Program, Kantara Initiative, The Advisory Board Company, Clancey, National, Army of the United States, FIDO Alliance, Classification, Growth, CEO, Digital, Infantry, NSS, Security agreement, Advisory board, Leadership, Lockheed Martin Transportation & Security Solutions, Intelligence, Industry, Special, Private sector, Moses Austin, IDEMIA, Foreign ownership, NIST, Control, Software, Austin Center for Design, University, Management, Operation

IDEMIA National Security Solutions (NSS), a subsidiary of IDEMIA, the worlds leading biometric and identity solutions provider, announced today the appointment of Patrick Clancey as Chief Executive Officer (CEO).

Key Points: 
  • IDEMIA National Security Solutions (NSS), a subsidiary of IDEMIA, the worlds leading biometric and identity solutions provider, announced today the appointment of Patrick Clancey as Chief Executive Officer (CEO).
  • Prior to joining NSS, Clancey served as Vice President of Strategy and Programs and Chief of Staff for IDEMIAs Global Digital Platforms organization.
  • He began his career in the private sector with Booz Allen Hamilton, after serving as an Infantry Officer in the U.S. Army.
  • National Security Solutions (NSS) is the Foreign Ownership, Control, or Influence (FOCI) mitigated IDEMIA subsidiary.

MarketWise Announces $150,000,000 Revolving Credit Facility

Retrieved on: 
Monday, November 1, 2021
Security agreement, Compliance, Research, BMO Harris Bank, Technology, HSBC Bank, Silicon Valley Bank, Line of credit, Failure, Tablet, Primary Dealer Credit Facility, NASDAQ, HSBC Bank USA, U.S. Securities and Exchange Commission, SEC, Debtor, Consumer, Risk, Wells Fargo, Social media, Software, Forward-looking statement, Company, LLC, Intention, Lynch, COVID-19, Growth, Privacy, Environment, Credit, LIBOR, Prospectus, Surety, GLOBE, Education, Form, Security (finance), Bank, Risk management

The relevant terms and covenants contained in the new Credit Facility are summarized below:

Key Points: 
  • The relevant terms and covenants contained in the new Credit Facility are summarized below:
    Provides maximum revolving loans up to $150 million and contains a $5 million sub-facility for letters of credit.
  • The Credit Facility has two financial covenants, an interest coverage covenant, and a leverage covenant, as well as customary affirmative and negative covenants.
  • Dale Lynch, Chief Financial Officer of MarketWise, commented, "We are very pleased to have the support of our banking partners.
  • The Company may use the proceeds of the Credit Facility to finance permitted acquisitions and for working capital and other general corporate purposes.

ESPERION Announces Plan for Transformative Long-Term Growth

Retrieved on: 
Monday, October 18, 2021
Death, Amendment, Research and development, Cholesterol, Awareness, ESPR, Adoption, Systematic review, Growth, Bempedoic acid, Physician, General officer, Security (finance), ANN, Security agreement, Ezetimibe, Cardiology, Patient, Exercise, Development, GLOBE, Research, U.S. Securities and Exchange Commission, Treasury, Administration, Company, Forward-looking statement, CEO, Twitter, NASDAQ, COVID-19, Pharmaceutical industry

ANN ARBOR, Mich., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced its plan to align operational and expense structure to better enable future growth for its two first-in-class oral medicines, NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) and prioritize its investment in CLEAR Outcomes. The Company also issued updated expense guidance for fiscal year 2021 and fiscal year 2022 reflecting lower than previously estimated operating costs and pre-announced preliminary, unaudited U.S. net product revenue of $10.5 to $11.0 million for the quarter ended September 30, 2021.

Key Points: 
  • ESPERION is fortunate to have two well-received first-in-class medicines approved and available, providing us the opportunity to become a leader in the cardiovascular market.
  • ESPERION revised its 2021 operating expense guidance and expects at least $20 million of savings from prior issued mid-point expense guidance.
  • ESPERION expects fiscal year 2022 operating expenses to be $220 to $240 million, inclusive of $25 million of non-cash, stock-based compensation expense.
  • A live audio webcast can be accessed on the investors and media section of the ESPERION website at investor.esperion.com.

HeadsUp Announces Steps to Closing Major Acquisition in Gaming Software Sector

Retrieved on: 
Tuesday, September 28, 2021
Disclosure, News, Partnership, USD, Press release, NDA, Solution, OTC, Intention, Software, Sport, Esports, LOI, Agreement, Due diligence, Private Securities Litigation Reform Act, Acquisition, Company, Dendrite International, Inc. v. Doe No. 3, Technology, Party, Blockchain, Security agreement, Contract, Acceleration, Industry, Online gambling

To date, HeadsUp has forwarded approximately USD $1,000,000 towards this transaction.

Key Points: 
  • To date, HeadsUp has forwarded approximately USD $1,000,000 towards this transaction.
  • The target acquisition operates under two entities based in Europe and are licensed in multiple international jurisdictions with contracts in place to provide leading edge software platforms.
  • There are over 50 customers that range from national government contracts in the lottery sector to private gaming operators in the online casino and sports betting industry.
  • About HeadsUp Entertainment International Inc.
    HeadsUp Entertainment International Inc. is a global gaming operator and media company focusing on online gaming, online poker, eSports, sports betting, online lottery, mobile 50/50, charity fundraising platforms, software and blockchain based payment solutions.